BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neuron
,
Neocentromeres
,
Doxorubicin
,
rs3825942
,
PRKCA
,
cell-cell adhesion
,
Leukemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
dopamine
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Liver Pharmacology and Xenobiotic Response Repertoire
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
Explore Curated Studies Results
Literature
Most Relevant Literature
Mathematical model of dopamine autoreceptors and uptake inhibitors and their influence on tonic and …
Aripiprazole as "dopamine sensitivity stabilizer"].
Impulse-dependent extracellular resting dopamine concentration in rat striatum in vivo.
The optical properties of gold nanoparticles with dopamine at different hydrogen ion concentration.
Inhibition of 50-kHz ultrasonic vocalizations by dopamine receptor subtype-selective agonists and an…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Dopamine in Neonate
Dopamine Rhythms in Health and Addiction
Dopamine and Norepinephrine in Shock Patients
Dopamine in Acute Decompensated Heart Failure II
Dopamine Responsivity in Gamblers
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ